Kraig Biocraft Labs Scales Spider Silk Production for Apparel Market
Event summary
- Kraig Biocraft Laboratories (OTCQB: KBLB) begins large-scale deployment of 1 million proprietary spider-silk silkworm eggs, targeting 10 metric tons of cocoons per month.
- Recombinant spider silk fibers achieve tensile strengths up to 1.79 gigapascals and elasticity above 38%, comparable to structural steel and Kevlar.
- Company focuses on apparel sector first due to lower regulatory barriers, faster product cycles, and market willingness to adopt new materials.
- Project Atlas aims to accelerate R&D with threefold increase in screening throughput and advanced genetic designs for higher-performance spider silk.
The big picture
Kraig Biocraft Labs is positioning itself at the intersection of genetic engineering and textile manufacturing, leveraging sericulture to produce recombinant spider silk at commercial scale. The company's focus on the apparel sector first aligns with broader industry trends where new materials often enter through faster-moving markets before expanding into more regulated sectors like aerospace and defense. Success in apparel could validate the platform's potential for broader industrial applications.
What we're watching
- Production Scaling
- Whether Kraig can sustain consistent output and meet commercial specifications at scale.
- Market Adoption
- How quickly high-performance and luxury apparel sectors integrate spider silk into products.
- R&D Advancements
- The pace at which Project Atlas delivers next-generation spider silk designs with enhanced properties.